Widely used:Recently Viewed
Clear All$7.18
$0.03
(0.42%)
As on 11-Oct-2024 09:30EDT
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$39 Mln
P/E Ratio
--
P/B Ratio
1.19
Industry P/E
--
Debt to Equity
0.01
ROE
-0.16 %
ROCE
-15.85 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$37.28 Mln
EBITDA
$39.94 Mln
Net Profit
$22.29 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Qilian International Holding Group (QLI)
| 86.25 | 13.43 | 64.68 | 91.47 | -29.16 | -- | -29.14 |
|
BSE Sensex*
| 2.17 | 3.95 | 4.48 | 8.42 | 11.81 | 20.20 | 11.17 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
|
|---|---|---|
|
Qilian International Holding Group (QLI)
| 4.34 | -72.11 |
|
S&P Small-Cap 600
| 13.89 | -17.42 |
|
BSE Sensex
| 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan... Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China. Read more
Chairman of the Board, President, CEO, COO & Chief Scientific Officer
Mr. Zhanchang Xin
Chairman of the Board, President, CEO, COO & Chief Scientific Officer
Mr. Zhanchang Xin
Headquarters
Jiuquan
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Qilian International Holding Group Ltd (QLI) stood at $ 51 Mln as on 30-Sep-23
The share price of Qilian International Holding Group Ltd (QLI) is $7.18 (NASDAQ) as of 11-Oct-2024 09:30 EDT. Qilian International Holding Group Ltd (QLI) has given a return of -29.16% in the last 3 years.
Qilian International Holding Group Ltd (QLI) has a market capitalisation of $ 39 Mln as on 11-Oct-2024. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Qilian International Holding Group Ltd (QLI) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Qilian International Holding Group Ltd (QLI) and enter the required number of quantities and click on buy to purchase the shares of Qilian International Holding Group Ltd (QLI).
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.
The CEO & director of Mr. Zhanchang Xin. is Qilian International Holding Group Ltd (QLI), and CFO & Sr. VP is Mr. Zhanchang Xin.
There is no promoter pledging in Qilian International Holding Group Ltd (QLI).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Qilian International Holding Group Ltd (QLI) | Ratios |
|---|---|
|
Return on equity(%)
|
-16.24
|
|
Operating margin(%)
|
-5.62
|
|
Net Margin(%)
|
-16.74
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Qilian International Holding Group Ltd (QLI) was No Profit.
